Buteyko breathing

Buteyko breathing is a breathwork practice developed by Konstantin Buteyko at the Soviet Academy of Sciences in the late 1950s. It is the most extensively studied reduced-volume breathing method in asthma management. It works by training the body to breathe less — deliberately quieter, slower breaths through the nose — building tolerance for carbon dioxide.

The practitioner breathes exclusively through the nose, sits relaxed, and follows guided reduced-breathing exercises that quiet the breath until a mild sensation of air hunger arises. The central instruction is to keep the breath light, soft, and slow — light enough that the air hunger stays tolerable. Progress is tracked through the Control Pause, a comfortable post-exhalation breath hold measured daily. Sessions run 5–20 minutes, practiced one to three times daily.

A typical session lasts 5–20 minutes, with daily Control Pause measurement adding under a minute. At introductory levels, practitioners report slowed breathing, a calmer mood, and increased awareness of habitual mouth-breathing. At established levels, sustained reduced breathing produces a steady mild air hunger together with a sense of warmth or relaxation. Transient effects in early practice include increased nasal mucus, mild headache, fatigue, and yawning as nasal airways reactivate.

Aggressive breath-holding can provoke lightheadedness, anxiety, or syncope; standard guidance keeps air hunger mild and manageable. Sickle cell disease, arterial aneurysm, uncontrolled hypertension, recent heart attack, and first-trimester pregnancy are contraindications. Asthma patients must not reduce inhaler or corticosteroid use without physician supervision. Pooled RCT evidence finds moderate effects on asthma control and consistent reductions in rescue and maintenance medication.^[1][2]

Konstantin Buteyko developed the method in the late 1950s at the Soviet Academy of Sciences in Novosibirsk, building on his observation that breathing depth correlated with clinical deterioration in critically ill patients. The Soviet Ministry of Health formally recommended it for asthma in 1985. It reached the West through Australia in the 1990s — where the first blinded randomized trial was conducted^[3] — and is now taught by several practitioner organizations worldwide.

Technique

The practitioner sits upright in a chair or cross-legged on a cushion, spine relaxed, shoulders dropped, jaw at rest. The mouth is closed throughout — nasal breathing is the foundation of the practice. A stopwatch or phone timer is the only required tool.

The method centers on breathing less than the body seems to want — softer inhalations, slightly longer exhalations, with a brief comfortable pause at the end of each out-breath. The goal is a mild, steady sensation of air hunger that is tolerable and can be sustained for several minutes. Progress is measured by the Control Pause: the practitioner exhales normally, pinches the nostrils closed, and times the interval until the first urge to breathe; values below ten seconds indicate severe breathing dysfunction, and the target for asthma management is above forty seconds.^[4] The most common technique error is holding the breath maximally rather than breathing lightly — this turns a carbon-dioxide tolerance exercise into a stress test and provokes rebound over-breathing.

At the introductory level, sessions last 5–10 minutes once daily, focused on nasal breathing and baseline Control Pause measurement. At the established level, sessions extend to 15–20 minutes practiced two or three times daily, sustaining mild air hunger for longer intervals with weekly Control Pause tracking. Clinically meaningful change in asthma symptoms builds over weeks to months.^[4]

The method is taught in several lineages — Buteyko Clinic International (Patrick McKeown) and the Buteyko Institute of Breathing and Health are the main Western organizations — with substantively similar protocols; a video-delivered version has also been evaluated in randomized form.^[5]

Setting & Preparation

A quiet indoor space is sufficient. No special environment, lighting, or equipment is needed beyond a timer.

A quiet indoor space and a few minutes of uninterrupted time are all that is needed. No music, no special lighting, no facilitator presence is required, though the practice is best learned without distractions in the first weeks. A timer is needed for Control Pause measurement.

When treating asthma, keep rescue medication within arm's reach throughout every session. Schedule sessions at least one hour after eating and before, not after, vigorous exercise. First-time practitioners should plan their first one to five sessions with a trained instructor — in person, by video call, or through a structured course — to confirm that air hunger is being kept mild rather than maximal, which is the most common technique error.

The practice works by training slower, quieter nasal breathing to reduce overall breath volume, which raises carbon dioxide tolerance and is thought to ease bronchial constriction and support a calmer nervous system state.^[3][7]

The dominant experience is a steady, mild sensation of air hunger held at a tolerable level — slowed breath, dropped shoulders, softened jaw. A calming shift is commonly reported, likely from the slowed rate and nasal breathing.^[8] The practice is undramatic: no perceptual peaks, no tetany. Unsought effects are common in the first weeks — increased nasal mucus, mild headache, fatigue, and yawning as nasal airways reactivate — and brief anxiety or lightheadedness can follow if air hunger is pushed past a comfortable level.

Adverse Effects

Contraindications

• Sickle cell disease (breath-holding may precipitate vaso-occlusive events)
• Arterial aneurysm (hemodynamic fluctuation risk)
• Uncontrolled hypertension
• Recent myocardial infarction or unstable angina
• First trimester of pregnancy (gentle nasal breathing only is advised in later pregnancy)
• Children under four years

• Type 1 diabetes (breathing changes may alter glucose dynamics)
• Epilepsy
• Uncontrolled hyperthyroidism
• Severe mental health conditions, including active psychosis or severe panic disorder
• Active asthma exacerbation (introduction should be deferred until stable)

These restrictions come from physiological reasoning and practitioner-organization guidance rather than epidemiological case data.

Substance Interactions

No pharmacokinetic interactions between Buteyko practice and specific substances have been documented.

The clinically relevant interaction is functional: consistent practice reduces the need for inhaled bronchodilators (short-acting β₂-agonists) and inhaled corticosteroids in asthma. Across multiple randomized trials, β₂-agonist and corticosteroid use fell substantially in Buteyko-trained groups.^[3][5][1][4] Any medication change must occur only under the supervision of the prescribing physician. Self-directed reduction of inhaled corticosteroids carries a meaningful risk of acute exacerbation; rescue inhalers must remain available throughout training.

No data are available on interactions with recreational substances, alcohol, or psychiatric medications.

Habituation

The practice carries low risk of compulsive use. Sessions are short, undramatic, and unrewarding in the way that arousing breathwork or substance-mediated states can be — there is little hedonic peak around which a compulsive pattern would form. The plausible failure mode is over-investment in the Control Pause as a metric: practitioners who track it obsessively or extend breath holds well beyond protocol risk the anxiety and lightheadedness described in the Adverse Effects section. Weekly rather than daily trend evaluation is the standard corrective.

If Distress Arises

The practitioner has full agency: breathing can return to normal at any moment, and doing so is the correct response to any distress. If air hunger becomes uncomfortable, stop the reduced-breathing exercise, breathe through the nose at a natural rhythm, and resume only when calm returns.

Stop immediately if any of the following arise: acute anxiety or panic, lightheadedness or vertigo, sharp headache, palpitations, chest tightness in an asthmatic that does not ease within a minute of normal breathing, or visual disturbance. If asthmatic, use the rescue inhaler as prescribed. A single difficult session is not a reason to stop practice permanently, but a recurring pattern of distress is a signal to consult an instructor or physician before continuing.

Progress is tracked through the Control Pause: a post-exhalation breath hold timed on waking, with values under ten seconds indicating significant breathing dysfunction and the target above forty seconds for asthma management.^[4] The first two weeks focus on restoring nasal breathing and establishing a baseline; weeks three through twelve add 15–20 minute reduced-breathing sessions practiced two to three times daily. After three months, the practice settles into a maintenance pattern with periodic Control Pause checks and physician-supervised medication review where applicable.

Moderate evidence. Across seven randomized controlled trials (n=375) and a 2026 meta-analysis, Buteyko breathing consistently reduces rescue and maintenance medication use in adult asthma, with a pooled standardized mean difference of −0.33 (95% CI −0.54 to −0.13) for asthma control and consistent direction in both adult and pediatric subgroups.^[2][1]

Limitations

The main limitation is the consistent gap between patient-reported improvement and objective airway function — symptom scores and medication use improve while FEV₁ and peak expiratory flow change little^[3][1] — compounded by small trial sizes, active-comparator designs that obscure a no-treatment baseline, and almost no controlled evidence for non-asthma indications.^[9]